Controversies in oncology: surgery for small cell lung cancer? It’s time to rethink the case

por Hoda, Mir Alireza, Klikovits, Thomas, Klepetko, Walter
Publicado 2018

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resec...

por Sinn, Katharina, Mosleh, Berta, Grusch, Michael, Klepetko, Walter, Hoetzenecker, Konrad, Klikovits, Thomas, Gompelmann, Daniela, Hoda, Mir Alireza
Publicado 2022

Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging: Consensus of the Austrian Mesothelioma Interest Group (AMIG)

por Geltner, Christian, Errhalt, Peter, Baumgartner, Bernhard, Ambrosch, Gerhard, Machan, Barbara, Eckmayr, Josef, Klikovits, Thomas, Hoda, Mir Alireza, Popper, Helmut, Klepetko, Walter
Publicado 2016

Lymph Node Log-Odds Ratio Accurately Defines Prognosis in Resectable Non-Small Cell Lung Cancer

por Benej, Michal, Klikovits, Thomas, Krajc, Tibor, Bohanes, Tomas, Schulte, Lisa, Hochmair, Maximilian Johannes, Watzka, Stefan, Mosleh, Berta, Hoetzenecker, Konrad, Aigner, Clemens, Hoda, Mir Alireza, Mueller, Michael Rolf
Publicado 2023

Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma

por Wang, Lu-Lu, Chen, Zheng-Sen, Zhou, Wen-Di, Shu, Jin, Wang, Xiao-Hua, Jin, Rui, Zhuang, Li-Li, Hoda, Mir Alireza, Zhang, Hao, Zhou, Guo-Ping
Publicado 2017

Author Correction: Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma

por Wang, Lu-Lu, Chen, Zheng-Sen, Zhou, Wen-Di, Shu, Jin, Wang, Xiao-Hua, Jin, Rui, Zhuang, Li-Li, Hoda, Mir Alireza, Zhang, Hao, Zhou, Guo-Ping
Publicado 2018

The landscape of small cell lung cancer metastases: Organ specificity and timing

por Megyesfalvi, Zsolt, Tallosy, Bernadett, Pipek, Orsolya, Fillinger, Janos, Lang, Christian, Klikovits, Thomas, Schwendenwein, Anna, Hoda, Mir Alireza, Renyi‐Vamos, Ferenc, Laszlo, Viktoria, Rezeli, Melinda, Moldvay, Judit, Dome, Balazs
Publicado 2021

The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity

por Dimic-Janjic, Sanja, Hoda, Mir Alireza, Milenkovic, Branislava, Kotur-Stevuljevic, Jelena, Stjepanovic, Mihailo, Gompelmann, Daniela, Jankovic, Jelena, Miljkovic, Milica, Milin-Lazovic, Jelena, Djurdjevic, Natasa, Maric, Dragana, Milivojevic, Ivan, Popevic, Spasoje
Publicado 2023

Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)

por Wright, Casey M., Kirschner, Michaela B., Cheng, Yuen Yee, O'Byrne, Kenneth J., Gray, Steven G., Schelch, Karin, Hoda, Mir Alireza, Klebe, Sonja, McCaughan, Brian, van Zandwijk, Nico, Reid, Glen
Publicado 2013

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma

por Hoda, Mir Alireza, Rozsas, Anita, Lang, Elisabeth, Klikovits, Thomas, Lohinai, Zoltan, Torok, Szilvia, Berta, Judit, Bendek, Matyas, Berger, Walter, Hegedus, Balazs, Klepetko, Walter, Renyi-Vamos, Ferenc, Grusch, Michael, Dome, Balazs, Laszlo, Viktoria
Publicado 2016

Management of malignant pleural mesothelioma – part 3: Data from the Austrian Mesothelioma Interest Group (AMIG) database

por Klikovits, Thomas, Hoda, Mir Alireza, Dong, Yawen, Arns, Madeleine, Baumgartner, Bernhard, Errhalt, Peter, Geltner, Christian, Machan, Barbara, Pohl, Wolfgang, Hutter, Jörg, Eckmayr, Josef, Studnicka, Michael, Flicker, Martin, Cerkl, Peter, Kirchbacher, Klaus, Klepetko, Walter
Publicado 2016

Apelin promotes lymphangiogenesis and lymph node metastasis

por Berta, Judit, Hoda, Mir Alireza, Laszlo, Viktoria, Rozsas, Anita, Garay, Tamas, Torok, Szilvia, Grusch, Michael, Berger, Walter, Paku, Sandor, Renyi-Vamos, Ferenc, Masri, Bernard, Tovari, Jozsef, Groger, Marion, Klepetko, Walter, Hegedus, Balazs, Dome, Balazs
Publicado 2014

Management of malignant pleural mesothelioma—part 2: therapeutic approaches: Consensus of the Austrian Mesothelioma Interest Group (AMIG)

por Hoda, Mir Alireza, Klikovits, Thomas, Arns, Madeleine, Dieckmann, Karin, Zöchbauer-Müller, Sabine, Geltner, Christian, Baumgartner, Bernhard, Errhalt, Peter, Machan, Barbara, Pohl, Wolfgang, Hutter, Jörg, Eckmayr, Josef, Studnicka, Michael, Flicker, Martin, Cerkl, Peter, Klepetko, Walter
Publicado 2016

Erythropoietin Receptor Expression Is a Potential Prognostic Factor in Human Lung Adenocarcinoma

por Rózsás, Anita, Berta, Judit, Rojkó, Lívia, Horváth, László Z., Keszthelyi, Magdolna, Kenessey, István, László, Viktória, Berger, Walter, Grusch, Michael, Hoda, Mir Alireza, Török, Szilvia, Klepetko, Walter, Rényi-Vámos, Ferenc, Hegedűs, Balázs, Döme, Balázs, Tóvári, József
Publicado 2013

Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells

por Ries, Alexander, Slany, Astrid, Pirker, Christine, Mader, Johanna C., Mejri, Doris, Mohr, Thomas, Schelch, Karin, Flehberger, Daniela, Maach, Nadine, Hashim, Muhammad, Hoda, Mir Alireza, Dome, Balazs, Krupitza, Georg, Berger, Walter, Gerner, Christopher, Holzmann, Klaus, Grusch, Michael
Publicado 2023

The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma

por Laszlo, Viktoria, Valko, Zsuzsanna, Ozsvar, Judit, Kovacs, Ildiko, Garay, Tamas, Hoda, Mir Alireza, Klikovits, Thomas, Stockhammer, Paul, Aigner, Clemens, Gröger, Marion, Klepetko, Walter, Berger, Walter, Grusch, Michael, Tovari, Jozsef, Waizenegger, Irene C., Dome, Balazs, Hegedus, Balazs
Publicado 2018

Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI

por Taghizadeh, Hossein, Unseld, Matthias, Spalt, Martina, Mader, Robert M., Müllauer, Leonhard, Fuereder, Thorsten, Raderer, Markus, Sibilia, Maria, Hoda, Mir Alireza, Aust, Stefanie, Polterauer, Stephan, Lamm, Wolfgang, Bartsch, Rupert, Preusser, Matthias, A., Kautzky-Willer, Prager, Gerald W.
Publicado 2020

Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin

por Ries, Alexander, Flehberger, Daniela, Slany, Astrid, Pirker, Christine, Mader, Johanna C., Mohr, Thomas, Schelch, Karin, Sinn, Katharina, Mosleh, Berta, Hoda, Mir Alireza, Dome, Balazs, Dolznig, Helmut, Krupitza, Georg, Müllauer, Leonhard, Gerner, Christopher, Berger, Walter, Grusch, Michael
Publicado 2023

Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis

por Mosleh, Berta, Schelch, Karin, Mohr, Thomas, Klikovits, Thomas, Wagner, Christina, Ratzinger, Lukas, Dong, Yawen, Sinn, Katharina, Ries, Alexander, Berger, Walter, Grasl‐Kraupp, Bettina, Hoetzenecker, Konrad, Laszlo, Viktoria, Dome, Balazs, Hegedus, Balazs, Jakopovic, Marko, Hoda, Mir Alireza, Grusch, Michael
Publicado 2023

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

por Ghimessy, Áron Kristof, Gellert, Áron, Schlegl, Erzsebet, Hegedus, Balazs, Raso, Erzsebet, Barbai, Tamas, Timar, Jozsef, Ostoros, Gyula, Megyesfalvi, Zsolt, Gieszer, Balazs, Moldvay, Judit, Renyi-Vamos, Ferenc, Lohinai, Zoltan, Hoda, Mir Alireza, Klikovits, Thomas, Klepetko, Walter, Laszlo, Viktoria, Dome, Balazs
Publicado 2019